A detailed history of Bank Of America Corp transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 578,760 shares of ARWR stock, worth $11.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
578,760
Previous 524,014 10.45%
Holding current value
$11.4 Million
Previous $13.6 Million 17.73%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.36 - $29.54 $1.06 Million - $1.62 Million
54,746 Added 10.45%
578,760 $11.2 Million
Q2 2024

Aug 14, 2024

BUY
$21.87 - $28.24 $1.38 Million - $1.79 Million
63,244 Added 13.73%
524,014 $13.6 Million
Q1 2024

May 15, 2024

SELL
$27.21 - $39.48 $3.4 Million - $4.93 Million
-124,817 Reduced 21.31%
460,770 $13.2 Million
Q4 2023

Feb 14, 2024

BUY
$21.2 - $31.03 $4.32 Million - $6.33 Million
203,886 Added 53.42%
585,587 $17.9 Million
Q2 2023

Aug 14, 2023

SELL
$25.16 - $41.38 $2.37 Million - $3.89 Million
-94,066 Reduced 19.77%
381,701 $13.6 Million
Q1 2023

May 12, 2023

SELL
$23.68 - $38.51 $4.51 Million - $7.34 Million
-190,544 Reduced 28.6%
475,767 $12.1 Million
Q4 2022

Feb 10, 2023

BUY
$28.0 - $40.56 $5.02 Million - $7.27 Million
179,280 Added 36.81%
666,311 $27 Million
Q3 2022

Nov 14, 2022

SELL
$29.63 - $48.31 $3.56 Million - $5.81 Million
-120,257 Reduced 19.8%
487,031 $16.1 Million
Q2 2022

Aug 12, 2022

SELL
$27.79 - $50.61 $6.1 Million - $11.1 Million
-219,644 Reduced 26.56%
607,288 $21.4 Million
Q1 2022

May 16, 2022

BUY
$39.62 - $69.97 $9.16 Million - $16.2 Million
231,243 Added 38.82%
826,932 $38 Million
Q4 2021

Feb 08, 2022

SELL
$58.09 - $82.51 $1.16 Million - $1.65 Million
-19,983 Reduced 3.25%
595,689 $39.5 Million
Q3 2021

Nov 15, 2021

BUY
$58.38 - $84.96 $2.98 Million - $4.33 Million
50,962 Added 9.02%
615,672 $38.4 Million
Q2 2021

Sep 13, 2021

BUY
$62.15 - $90.32 $35.1 Million - $51 Million
564,710 New
564,710 $46.8 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.08B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.